Atenor SA (LON:0NG6)
2.850
-0.050 (-1.72%)
At close: Oct 27, 2025
Atenor Revenue
Atenor had revenue of 53.39M EUR in the half year ending June 30, 2025, with 72.02% growth. This brings the company's revenue in the last twelve months to 239.81M, up 31.44% year-over-year. In the year 2024, Atenor had annual revenue of 321.30M with 308.74% growth.
Revenue (ttm)
239.81M EUR
Revenue Growth
+31.44%
P/S Ratio
0.72
Revenue / Employee
2.16M EUR
Employees
111
Market Cap
147.91M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 321.30M | 242.69M | 308.74% |
| Dec 31, 2023 | 78.61M | 37.60M | 91.68% |
| Dec 31, 2022 | 41.01M | -133.11M | -76.45% |
| Dec 31, 2021 | 174.12M | 42.13M | 31.92% |
| Dec 31, 2020 | 131.99M | 24.78M | 23.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |